Ads
related to: stelara for crohn's disease- COSENTYX® Connect
Sign Up Today for Real
Support & Personal Solutions.
- Paying for COSENTYX®
See Ways We Make COSENTYX®
Affordable & Accessible.
- Share Your COSENTYX Story
If You're Taking COSENTYX®, Learn
How You Can Share Your Story.
- Patient Support Program
Learn About a Free Personal
Support Program for COSENTYX®.
- COSENTYX® Connect
Search results
From Nurse To Patient: My Journey With Crohn’s Disease
Women's Health via Yahoo News· 2 years agoAs a healthcare professional, Alison spent her days doing endoscopies, which are one of the many...
AbbVie's (ABBV) Skyrizi Crohn's Disease Study Meets Goals
Zacks via Yahoo Finance· 7 months agoAbbVie's (ABBV) Skyrizi met both primary endpoints of non-inferiority for clinical remission at week...
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Zacks via Yahoo Finance· 2 weeks agoBristol Myers BMY announced that a late-stage study on orally-administered Zeposia (ozanimod) in...
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Benzinga via Yahoo Finance· 11 months agoThe FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active...
AbbVie's (ABBV) Rinvoq Meets Crohn's Disease Study Goals
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) Rinvoq achieves statistical significance with its co-primary endpoints of clinical...
Amgen's (AMGN) Stelara Biosimilar Meets Psoriasis Study Goal
Zacks via Yahoo Finance· 2 years agoInitial data from a late-stage study comparing Amgen's (AMGN) Stelara biosimilar candidate with the...
Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast
Reuters via Yahoo News· 10 months agoJohnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster...
What Could This Drug News Mean for AbbVie?
Motley Fool· 2 years agoIn late July, AbbVie (NYSE: ABBV) applied for a new indication with the European Medicines Agency (EMA) for Rinvoq to treat adult patients with...
Lilly's bowel disease drug succeeds in late-stage study
Reuters via Yahoo News· 6 months agoThe drug was also shown not to be inferior to Johnson & Johnson's Stelara in helping symptoms of the...
Johnson & Johnson Clocks 12% Q4 Revenue Growth, Led By Cancer and Crohn's Disease Drugs
Benzinga via Yahoo Finance· 3 months agoOn Tuesday, Johnson & Johnson (NYSE:JNJ) reported fourth-quarter 2023 adjusted earnings of $2.29 per...
Ads
related to: stelara for crohn's disease